Xylutide 40 mg (Enzalutamide)
| Active Ingredient | Enzalutamide |
|---|---|
| Manufacturers | Cipla Limited |
| Indications | Prostate cancer |
| Strength | 40mg |
| Packaging | 4 capsules in 1 strip |
| Delivery Time | 6 To 15 days |
Xylutide 40 mg contains Enzalutamide, a powerful androgen receptor inhibitor used in the treatment of advanced prostate cancer. It is primarily prescribed to patients with metastatic castration-resistant prostate cancer (mCRPC) or non-metastatic CRPC, especially when hormone therapy or surgical castration is no longer effective.
Enzalutamide works by blocking the effect of androgens (male hormones like testosterone) that fuel the growth of prostate cancer cells. Xylutide 40 mg is taken orally and is often used as a part of a long-term treatment plan under an oncologist’s supervision.
Important: Always take Enzalutamide exactly as prescribed. Regular medical check-ups, including blood tests and monitoring of side effects, are crucial during treatment.








There are no reviews yet.